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Abstract
Background: Although tuberculosis (TB) patients often incur high costs to access TB-related services, it was unclear
beforehand whether the implementation of universal health coverage (UHC) in Indonesia in 2014 would reduce
direct costs and change the pattern of care-seeking behaviour. After its introduction, we therefore assessed TB
patients’ care-seeking behaviour and the costs they incurred for diagnosis, and the determinants of both.
Methods: In this cross sectional study, we interviewed adult TB patients in urban, suburban, and rural districts of
Indonesia in July–September 2016. We selected consecutively patients who had been treated for TB in primary
health centers for at least 1 month until we reached at least 90 patients in each district. After establishing which
direct and indirect costs they had incurred during the pre-diagnostic phase, we calculated the total costs (in US
Dollars). To identify the determinants of these costs, we applied a general linear mixed model to adjust for our
cluster-sampling design.
Results: Ninety-three patients of the 282 included in our analysis (33%) first sought care at a private clinic. The
preference for such clinics was higher among those living in the rural district (aOR 1.88, 95% CI 0.85–4.15, P = 0.119)
and among those with a low educational level (aOR 1.69, 95% CI 0.92–3.10, P = 0.090). Visiting a private clinic as the
first contact also led to more visits (β 0.90, 95% CI 0.57–1.24, P < 0.001) and higher costs than first visiting a Primary
Health Centre, both in terms of direct costs (β = 16.87, 95%CI 10.54–23.20, P < 0.001) and total costs (β = 18.41,
95%CI 10.35–26.47, P < 0.001).
Conclusion: Despite UHC, high costs of TB seeking care remain, with direct medical costs contributing most to the
total costs. First seeking care from private providers tends to lead to more pre-diagnostic visits and higher costs. To
reduce diagnostic delays and minimize patients’ costs, it is essential to strengthen the public-private mix and
reduce the fragmented system between the national health insurance scheme and the National TB Programme.
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Background
Studies in Asian countries suggest that the private
healthcare sector has the potential to play an important
role in national and global tuberculosis (TB) control [1–
4]. Many studies have shown that patients initially visit
private providers to relieve them from TB-related symp-
toms [5]. In Indonesia, many patients also prefer first to
seek care from private providers [4]. However, private
providers often fail to comply with TB practice guide-
lines, including those for the screening and diagnosis of
TB cases [4, 6]. In the pre-diagnostic phase, failure to
comply with TB practice guidelines may lead to missed
TB cases. Patients who continue to have TB related
symptoms then have many healthcare visits [7], leading
to diagnostic delays and high costs during seeking care
[8, 9]. This eventually worsens disease prognosis at the
individual level, increases costs in the household level,
and spreads TB in the community [8, 10].
In 2014, Indonesia started implementing a universal
health coverage (UHC) scheme, also called the Indones-
ian National Health Insurance scheme (Jaminan Keseha-
tan Nasional, JKN), to ensure people’s access to
healthcare. This insurance scheme is managed by the
Social Security Agency for Health (Badan Penyelenggara
Jaminan Sosial Kesehatan, BPJS-K) and covers all essen-
tial care services, including TB diagnostic tests through
healthcare providers that are linked to the BPJS-K [9,
11]. In the first 4 years after the JKN was implemented,
the number of private providers linked to the BPJS-K –
clinics and solo practices alike – increased substantially,
from 6369 private providers to 11,507 [12].
However, BPJS-K is not directly linked to the network
of the Indonesian National Tuberculosis Program
(NTP), which are national level government boards that
are responsible for TB control. Private providers that are
linked to the BPJS-K are therefore also not necessarily
linked to the NTP. Responding to this problem, the
NTP launched a guideline of TB care to coordinate the
care with the BPJS-K [13]. Although there has been no
direct linkage between the NTP and BPJS-K, the private
providers that are linked with BPJS-K can conduct the
TB tests in their laboratories, if available, or can refer
suspected TB patients for diagnostic tests to a BPJS-K-
linked facility [13]. All consultation and diagnostic test
fees are covered by the BPJS-K. If the suspected patient
has received the final TB diagnosis, the private providers
can refer the patient to the NTP-linked facilities to re-
ceive free TB treatment. As most TB patients seek initial
care with a private provider [6], this coordinated scheme
between BPJS-K and the NTP is assumed to reduce pa-
tient’s direct costs during the pre-diagnostic phase.
Nevertheless, there is no evidence available on the
costs incurred during the pre-diagnostic phase of TB
and TB patients’ care seeking behaviour since the
implementation of UHC in Indonesia. It is therefore un-
clear to which extent UHC has saved patients from high
costs during this phase. The aims of this study are to as-
sess the costs incurred before diagnosis by patients seek-
ing care for TB after the implementation of UHC in
Indonesia, and to assess care-seeking behaviour of TB
patients in this period on the basis of the first contact fa-
cility and the number of healthcare visits.
Methods
Study design and setting
To assess patients’ TB care-seeking behaviour and the
costs they incurred during the pre-diagnostic phase, we
conducted a cross-sectional study that was a part of a
larger study on measuring catastrophic costs in
Indonesia [9]. In this study, we interviewed patients who
had undergone TB treatment in PHCs (i.e. public facil-
ities for primary-level care). We selected three districts
in Java, the most populous island of Indonesia, purpos-
ively to represent urban (Jakarta), suburban (Depok),
and rural (Tasikmalaya) areas of Indonesia.
Study population
We included all subjects who met the inclusion criteria
of our main study, which were adult patients who had
received TB treatment in a PHC for at least 1 month.
We excluded extra-pulmonary cases, as these are diag-
nosed using different methods that may result in bias on
pre-diagnostic costs.
Sampling method
The sample size and sampling methods in this study
followed that of our larger study, which assumed an inci-
dence of catastrophic costs due to TB of 20–30% [9].
We used a sample size formula for a cross sectional
study (Zα2.p.q/d2) with assumptions of a power of 0.90
and an error of 0.05. With a ratio of TB patients of 1:1:1
in each district, we required 90 patients per district. In
each district, we included all the PHCs that were linked
to the Indonesian NTP in our sampling framework, and
then randomly selected five PHCs per district. We chose
only PHCs since most of TB patients were treated in
PHCs. In each PHC, we selected consecutively adult TB
patients until we reached at least 90 patients per district.
If the sample size was not reached, we randomly selected
additional PHCs until we obtained at least 90 patients
per district. In total, 19 PHCs were included in our
study.
Data collection
All patients were interviewed by four medical students
and six public health graduates we had recruited and
trained for the purpose. As a part of our main study on
measuring catastrophic costs, the interview was
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conducted during the TB treatment phase – 48% of
patient in their intensive phase and 52% of patients in
their continuous phase [9]. To interview the patients
and/or the drug observer who accompanied each pa-
tient as a direct observation of treatment (DOT) sup-
porter, these interviewers used the adapted and
validated Bahasa Indonesia version of the Tool to Es-
timate Patient Costs [14].
Retrospectively, each respondent listed each healthcare
facility he or she had visited between developing TB-
related symptoms (e.g., chronic cough, bloody cough,
weight loss, or night sweating) and the establishment of
their TB diagnosis [14]. We also calculated the number
of healthcare visits and costs incurred during the pre-
diagnostic phase, and then assessed the determinants of
the number of visits and costs.
Care seeking behavior
First, to assess patients’ care-seeking behaviour, we
established the nature of their first contact facility, i.e., a
primary health centre (PHC); a private clinic (whether a
solo practice or part of a multiple practice); a public hos-
pital; a private hospital; or ‘other’, such as a pharmacy, a
practitioner of alternative medicine, or a mantri (i.e., a
registered nurse practicing as an unauthorized phys-
ician). We then assessed whether the first contact facility
was associated with the district (urban/suburban/rural),
household income level (poor/non-poor household),
educational level (low/middle-high), health insurance
status (being covered/not being covered by the BPJS-K
scheme), and formal employment (yes/no).
Number of visits
Second, we calculated the number of healthcare visits
made during the pre-diagnostic phase. To assess the de-
terminants of the number of visits, we also included first
contact as an independent variable, together with the
other independent variables.
Costs of care seeking
Third, we asked patients the details of all the types of
cost they had incurred in each facility visited during the
pre-diagnostic phase, i.e., direct medical costs, direct
non-medical costs, and indirect costs related to seeking
care for their TB-related symptoms. The definitions of
cost items used in this study conformed with the WHO
handbook on TB costs survey [15]. The direct medical
costs included all out-of-pocket (OOP) payments to the
healthcare facilities for medical fees, such as administra-
tive charges and the cost of drugs, laboratory analyses,
or X-ray examinations. The direct non-medical costs in-
cluded the cost of food and travel for patients and/or
their guardian during their visits to healthcare facilities.
The indirect costs consisted of loss of income incurred
by the patients and their guardians on their visits to
healthcare facilities. The total costs were the sum of dir-
ect medical costs, direct non-medical costs, and indirect
costs. All costs were provided in Indonesian Rupiahs
(IDR) and then converted to US dollars using the World
Bank’s average exchange rate for 2015 (1 USD = 13,
389.41 IDR). We then assessed whether the total costs,
direct costs, and indirect costs were associated with the
first contact, district, household income level, educa-
tional level, health insurance status, and formal
employment.
Data management and analysis
Data were double-entered into Microsoft Excel 2010 and
EpiInfo version 7 (CDC, Atlanta) and then exported to
IBM SPSS 21 for data analysis. Number of visits and
costs data were displayed as means and their 95% confi-
dence intervals (CIs) while categorical variables as num-
bers and proportions (%). To examine the determinants
of the patients’ first contact facility, the number of visits,
and their costs during the pre-diagnostic phase, we ap-
plied the generalized linear mixed models (GLMMs)
with random effects to adjust for our cluster sampling
design (19 PHCs), since we selected the PHCs randomly.
We assessed the goodness of fit for models by examining
the Akaike corrected and the Bayesian information cri-
terion provided by SPSS. To analyse the determinants of
the first health-service contact, we estimated crude odds
ratios (cORs), adjusted odds ratios (aORs), and their 95%
CIs with a target distribution of multinomial regression.
To analyse the determinants of number of visits and
costs incurred by patients and their family, we estab-
lished crude and adjusted GLMM regression coefficients
(β) and their 95% CIs with a target distribution of linear
regression.
Ethical issues
Before the interview, we provided all respondents with a
written and oral explanation of the study. Only those
who had signed an informed consent form were inter-
viewed. Before the study, we received ethical clearance
from the Ethical Committee at the Faculty of Medicine
of Universitas Indonesia–Cipto Mangunkusumo Hos-
pital, Jakarta, Indonesia (No. 416/UN2.F1/ETIK/VI/
2016).
Results
We included the interviews of 282 patients. Whereas a
PHC had been the first point of diagnostic care-seeking
for 45% of them, 33% had first sought care at a private
clinic, 11% at a public hospital, 7% at a private hospital,
and 4% at a pharmacy, practitioner of alternative medi-
cine, or other healthcare provider. (Table 1) A majority
of patients (58%) had been diagnosed at a PHC. The
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remainder had been diagnosed at a private clinic
(15%), public hospital (18%), or private hospital (9%)
before they were referred to PHCs for TB treatment.
Figure 1 shows the most common care-seeking pat-
terns identified in this study. Seventeen percent of pa-
tients had been diagnosed during their first visit at
PHC. This was higher than the percentage of patients
who had been diagnosed during their first visit to any
of the other healthcare settings. All patients who had
first sought care at a pharmacy, practitioner of alter-
native medicine or other healthcare provider had
moved to another provider – usually a private clinic
– for their second visit.
Table 2 shows that in the urban and suburban dis-
tricts, more patients initially sought care at a PHC than
at another healthcare facility. In contrast, among pa-
tients with low education level, the proportion of those
who initially sought care at a private clinic was higher
than at another healthcare facility.
Table 3 shows that more patients in the rural district
preferred to seek care first at a private clinic (cOR 2.27,
95% CI 1.14–4.53, P = 0.020). Seeking inital care at a pri-
vate provider rather than a PHC was also greater among
patients with a low educational level than among those
with a middle to high educational level (cOR 1.93, 95%
CI 1.09–3.41, P = 0.024). Despite the borderline statis-
tical significance of the result, multivariable analysis
Table 1 First point of care and place of TB diagnosis of a
sample of 282 TB patients
Healthcare service First point of care Place of diagnosis
N % n %
Primary health centre 127 45 164 58
Private clinic 93 33 43 15
Public hospital 32 11 50 18
Private hospital 20 7 25 9
Other health providera 10 4 0 0
aPharmacy, practitioner of alternative medicine, mantri, or other
health provider
Fig. 1 The care-seeking pattern of TB patients onwards of their first contact. The figure shows the top 10 care-seeking patterns that followed the
first contact with each of the following: a a PHC, b a private clinic, c a public hospital, d a private hospital, and e a pharmacy, practitioner of
alternative medicine, or other health provider. Each coloured block indicates the type of healthcare provider visited. Each rightmost box indicates
the provider where the TB diagnosis was confirmed. The percentages to the right of each graph are the percentages of each patterns. Eighteen
percents of patterns are not captured in these graphs
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Table 2 Distribution of patients by point of first contact
Characteristics Primary health centre
N (%)
Private clinic
N (%)
Public hospital
N (%)
Private hospital
N (%)
Other health providera
N (%)
Total
Number of patients 127 (45) 93 (33) 32 (11) 20 (7) 10 (4) 282 (100)
Districts
Urban 51 (54) 26 (27) 11 (12) 4 (4) 3 (3) 95 (100)
Suburban 40 (44) 25 (28) 10 (11) 13 (14) 2 (2) 90 (100)
Rural 36 (37) 42 (43) 11 (11) 3 (3) 5 (5) 97 (100)
Household income levelb
Non-Poor 51 (48) 30 (28) 12 (11) 13 (12) 1 (1) 107 (100)
Poor 76 (43) 63 (36) 20 (11) 7 (4) 9 (5) 175 (100)
Education levelc
Middle-High 89 (49) 50 (27) 22 (12) 15 (8) 7 (4) 183 (100)
Low 38 (38) 43 (43) 10 (10) 5 (5) 3 (3) 99 (100)
National health insurance
Not covered 48 (44) 41 (37) 8 (7) 7 (6) 6 (5) 106 (100)
Covered 79 (46) 52 (30) 24 (14) 13 (8) 4 (2) 176 (100)
Workers in informal sectors
No 41 (51) 25 (31) 7 (9) 5 (6) 3 (4) 81 (100)
Yes 86 (43) 68 (34) 25 (12) 15 (7) 7 (3) 201 (100)
a Pharmacy, alternative medicine, mantri, and other health providers
b household earning below 1.9 USD per capita per day was classified as a poor household
c a patient who did not graduate from elementary school was classified as having low education level
Table 3 Determinants of the first point of health-service contact (private clinic or primary health centre)
Characteristics Private clinic
N (%)
PHCa
N (%)
P cOR (95% CI) P aOR (95% CI)
Districts
Urbana 26 (27) 51 (54) 1 1
Suburban 25 (28) 40 (44) 0.557 1.24 (0.60–2.55) 0.462 1.32 (0.63–2.76)
Rural 42 (43) 36 (37) 0.020 2.27 (1.14–4.53) 0.119 1.88 (0.85–4.15)
Household income level‡
Poor 63 (36) 76 (43) 0.355 1.32 (0.74–2.35) 0.824 1.07 (0.57–2.01)
Non-Poora 30 (28) 51 (48) 1 1
Education level±
Low 43 (43) 38 (38) 0.024 1.93 (1.09–3.41) 0.090 1.69 (0.92–3.10)
Middle to higha 50 (27) 89 (49) 1 1
National health insurance
Covered 52 (30) 79 (46) 0.468 0.81 (0.46–1.43) 0.768 0.92 (0.51–1.65)
Not covereda 41 (37) 48 (44) 1 1
Workers in informal sectors
Yes 68 (34) 86 (43) 0.364 1.32 (0.72–2.41) 0.284 1.40 (1.76–2.58)
Noa 25 (31) 41 (51) 1 1
aReference category; ‡ household earning below 1.9 USD per capita per day was classified as a poor household; ± a patient who did not graduate from
elementary school was classified as having low education level
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showed that the odds of seeking care at a private clinic
rather than at a PHC was higher in the rural district
(aOR 1.87, 95% CI 0.85–4.15, P = 0.119) and in patients
with low education level (aOR 1.69, 95% CI 0.51–1.65,
P = 0.090). There were no statistically significant differ-
ences regarding first contact preferences for the follow-
ing: between patients with insurance and without
insurance; between patients living in a poor household
and a non-poor household; and between patients with
and without formal work.
The average number of visits during the pre-
diagnostic phase was 2.56 (95% CI 2.41–2.71). Pa-
tients who first sought care at private clinics and
other health care providers had more visits until their
diagnosis was confirmed than patients who first vis-
ited a PHC (aβ 0.90, 95% CI 0.57–1.24, P < 0.001 for
private clinics and aβ 1.77, 95% CI 0.97–2.57, P <
0.001 for other health care providers). (Table 4)
There were no statistically significant differences in
the number of visits regarding the following
determinants: district, household income level, educa-
tional level, having insurance, and employment status.
The average total cost incurred during the pre-
diagnostic phase was USD 22 (95% CI 18–26). It con-
sisted mainly of direct costs (USD 16, 95% CI 13–19).
(Table 5) Visiting a private clinic as the first point of
contact led to statistically significantly higher costs than
visiting a PHC as the first contact, both in terms of dir-
ect costs (β 16.87, CI 95% 0.54–23.20, P < 0.001) and of
total costs (β 18.41, CI 95% 10.35–26.47, P < 0.001). Pa-
tients who visited a private hospital as the first contact
also incurred statistically significantly higher direct costs
(β 28.38, CI 95% 17.18–39.58, P < 0.001) and total costs
(β 24.96, CI 95% 10.64–39.28, P = 0.001) than those visit-
ing a PHC as the first contact. The direct medical costs
incurred by patients who first sought care at private
clinics (USD 21; 95% CI USD 15–28) and private hospi-
tals (USD 32; 95% CI USD 17–48) were significantly
higher than those who first sought care at PHCs (USD 5;
95% CI USD 3–7), while travel costs between private
Table 4 Determinants of the number of healthcare visits during the pre-diagnostic phase
Variables No of visits
mean (95% CI)
cβ (95% CI) P aβ (95% CI) P
Total number of visits 2.56 (2.41–2.71)
First contact facility
Primary Health Centre 2.18 (1.96–2.41) Ref Ref
Private clinic 3.06 (2.83–3.30) 0.89 (0.57–1.22) < 0.001 0.90 (0.57–1.24) < 0.001
Public hospital 2.13 (1.77–2.48) − 0.07 (− 0.55–0.41) 0.766 − 0.08 (− 0.56–0.41) 0.750
Private hospital 2.65 (2.06–3.24) 0.44 (− 0.14–1.02) 0.140 0.39 (− 0.20–0.99) 0.194
Other health provider 3.9 (2.66–5.14) 1.70 (0.91–2.49) < 0.001 1.77 (0.97–2.57) < 0.001
District
Urban 2.49 (2.18–2.63) Ref Ref
Suburban 2.63 (2.37–2.90) 0.21 (−0.29–0.70) 0.406 0.17 (− 0.31–0.66) 0.484
Rural 2.56 (2.34–2.78) 0.11 (−0.39–0.62) 0.667 −0.05 (− 0.57–0.48) 0.861
Household income levela
Poor 2.58 (2.38–2.77) 0.07 (−0.25–0.40) 0.656 0.02 (−0.34–0.31) 0.927
Non-poor 2.53 (2.29–2.78) Ref Ref
Education levelb
Low 2.66 (2.39–2.92) 0.16 (−0.17–0.49) 0.336 0.14 (−0.22–0.43) 0.526
Middle-high 2.51 (2.32–2.70) Ref Ref
National health coverage
Covered 2.58 (2.37–2.79) 0.07 (−0.25–0.39) 0.673 0.18 (−0.13–0.49) 0.259
Not covered 2.53 (2.32–2.74) Ref Ref
Workers in informal sectors
Yes 2.55 (2.37–2.72) −0.07 (−0.41–0.27) 0.692 −0.12 (− 0.44–0.21) 0.480
No 2.59 (2.29–2.90) Ref Ref
β is the GLMM coefficient of the expected change in the number of visits compared to the reference category; cβ crude coefficient β; aβ adjusted coefficient β; CI
confidence interval; Ref reference; P value of significance; a household earning below 1.9 USD per capita per day was classified as a poor household; b a patient
who did not graduate from elementary school was classified as having low education level
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providers and PHCs did not differ significantly (See
Additional file 1). Despite involving a higher number of
visits, first visiting a pharmacy, practitioner of alternative
medicine or other health provider did not lead to signifi-
cantly higher costs than those incurred by patients who
first sought care at a PHC. Between districts, insurance
coverage, household income level, and education level,
the differences in the total costs, direct costs, and indir-
ect costs incurred were not statistically significant. Indir-
ect costs during the pre-diagnostic phase were
associated with employment status. In addition, patients
who were formally employed had higher indirect costs
than patients who did not have a job or were not for-
mally employed (β 3.92, CI 95% 0.88–6.96, P = 0.012).
No other variables determined the indirect costs.
Discussion
Our results show that patients still incur high costs
while seeking TB care. Direct medical costs contributed
most to the total costs of TB care seeking, despite the
implementation of UHC in Indonesia. Most patients
who were treated for TB in a PHC had started their
care-seeking in private sector. The number of those who
first sought care at a private clinic first was significantly
greater among patients who lived in the rural district
and among those with a lower educational level. Before
being diagnosed with TB, patients who had first sought
care at such clinics made more healthcare visits and had
higher costs than those whose first point of contact was
a PHC.
Rural patients’ preference for starting to seek care at a
private clinic may have been affected by the greater dis-
tance they had to travel to a PHC. The number of PHCs
in these areas is limited, the cost of transport to them is
higher, and the waiting times can be long [16]. This en-
courages patients to visit any private healthcare provider
– whether clinic, solo practice or other – that is closer
to their house.
However, to have their diagnosis of TB confirmed, pa-
tients whose first point of contact was a private clinic
needed more visits than those who first visited a PHC.
This higher number of visits may have been due to the
poorer TB-service readiness of private clinics, most of
which – particularly private solo practices – do not have
appropriate facilities for TB diagnostic tests, i.e., a la-
boratory for sputum smear examination [17]. To solve
this problem, we suggest that most clinics use sputum
smear fixation and deliver the preparation for diagnosis
to a referral PHC or a clinic linked with the BPJS-K [13].
Our findings also suggest that seeking care first at a
private clinic or private hospital led to significantly
higher costs during the pre-diagnostic phase. Except
when covered by health insurance, each visit to a private
hospital is costly [18, 19]. This explains why, despite the
limited number of visits, high costs were incurred at pri-
vate hospitals. However, while the high cost of private
clinics sometimes resulted from the high costs per visit,
it also may be resulted from a high number of visits or
from a combination of both.
Patients who first sought care at a pharmacy, practi-
tioner of alternative medicine or other healthcare pro-
vider had a higher number of visits than those who
started care-seeking at PHCs. However, this high num-
ber of visits did not lead to significantly higher costs for
diagnosis. This may have been because the costs of sim-
ple, generic medicine in a pharmacy or of consultations
for alternative medicine were low.
Despite the implementation of UHC in Indonesia, ex-
cessive visits and costs during the pre-diagnostic phase
remain. Although this study did not compare the situ-
ation before and after the implementation of UHC, we
showed that there were no significant differences in
number of visits and costs between patients who were
and were not covered by national health insurance.
Excessive visits and costs can result in diagnostic de-
lays, potential catastrophic costs during treatment, and
poor outcome [10, 20]. To prevent high number of visits
and high costs, the integration between the national
health insurance and the NTP, which is still fragmented,
should be improved [21]. Currently, there has been no
direct link between the national health insurance system
and the NTP. Private providers – despite linked to the
BPJS-K – often unaware of the national tuberculosis
guidelines and of TB referral system under the NTP [4].
The current practice of TB current guidelines in private
providers seems not optimal. There has been also lack of
incentives from the national health insurance to improve
the quality of TB care in private sector [22]. Therefore,
comprehensive strategies are imperative. To solve the
fragmented system in TB care, the national health insur-
ance needs to develop a mechanism of incentives
whereby private physicians and clinics can screen and
diagnose TB cases accurately and refer the case to facil-
ity where TB diagnostic tests and treatment are fully
covered. In its pay-for-performance criteria [22], for ex-
ample, BPJS-K should include the quality of the TB ser-
vices a clinic provides. A contract of service provision
that is signed between the BPJS-K and private providers
should consider the readiness of the TB services includ-
ing the availability of diagnostic tests, the adherence with
TB management guidelines, and prior attendance of TB
training. In addition, the strategies should include efforts
to increase patients’ awareness, to reduce stigma and
discrimination, to improve TB diagnostic options, and to
increase the number of PHCs in rural districts.
This study has two main limitations. The first is our
collection of data from patients who had ended up at a
PHC for TB treatment, and thus our exclusion of those
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who had had TB treatment from a private provider. This
may have led us to overestimate PHCs as the first point
of contact and to underestimate the number of pre-
diagnostic visits and the costs incurred during the pre-
diagnostic phase. It may also have led to a misleadingly
high figure for the number of visits – by at least one visit
– by patients whose first point of care had not been
been a PHC, particularly if this visit had involved a
healthcare provider that could not itself diagnose TB.
The second limitation is that, since we relied on patients’
memory to obtain the information, the number of visits
and the costs incurred may also have been affected by
recall bias. A patient may not remember the frequency
and cost of buying medicine in a drug store or phar-
macy, and thereby underestimate the number of visits
and the total pre-diagnostic costs.
The provision of TB services in Indonesia is similar to
health-service delivery in other high TB-burden coun-
tries in Asia that need to improve their public-private
mix. However, our findings require careful
generalization before being applied to other countries or
even to other regions of Indonesia. As this study was
conducted only on the island of Java, it does not neces-
sarily reflect the situation throughout Indonesia.
Conclusion
Despite the UHC, high costs of TB seeking care remain,
with direct medical costs contributing most to the total
costs. The preference of people with TB first to seek
diagnosis from a private provider rather than a PHC
leads to more pre-diagnostic visits and higher costs. The
UHC scheme alone is not enough to improve TB control
and reduce patients’ costs. A comprehensive strategy is
required to improve TB-related services in the private
healthcare sectors. To reduce diagnostic delays and
minimize patients’ costs, it is essential to reduce the
fragmented system between the national health insur-
ance scheme and the National TB Programme, to im-
prove the quality of TB care in the private sector, and to
improve the availability of PHCs, particularly in rural
areas.
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